BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

27 hedge funds and large institutions have $6.34M invested in Bellerophon Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$145K
2
+$113K
3
+$80K
4
E
Ergoteles
New York
+$67K
5
HF
HRT Financial
New York
+$66K

Top Sellers

1
-$1.31M
2
-$994K
3
-$514K
4
CCM
CAAS Capital Management
New York
-$508K
5
GCP
GSA Capital Partners
United Kingdom
-$330K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
1
2